CD274 and neoplasm: As shown in Fig. 4b, c, PLK1122DC_TriVax alone had moderate effects in comparison to those with Ova55 peptides, whereas complete tumour regression was accomplished in the majority of the mice (seven out of eight mice) when administered in combination with anti-PD-L1 Abs.